Hims and Hers shares fall 10% as FTC sues company over data, billing practices

19 hours ago

Humana tops estimates, maintains profit outlook as medical costs stay in line

19 hours ago

Why shareholders are suing Novo Nordisk over next-generation weight-loss drug

1 day ago

Jim Cramer says Wall Street is fleeing the AI trade and buying these stocks instead

1 day ago

Kentucky Gov. Beshear calls on Mitch McConnell to prove he can serve or resign

1 day ago

McConnell still not cleared to go back to work as he recovers from fall: Doctors

1 day ago

Consolidated food supply may be worsening cyclospora outbreaks, experts say

2 days ago

FedEx is chasing the GLP-1 boom. Why healthcare logistics means big business

2 days ago

Here are 4 forces that drove a tough week for stocks

4 days ago

CDC says massive cyclospora outbreak is now in nine states

5 days ago

Cyclospora outbreak tests RFK Jr.'s promise to overhaul food system

5 days ago

Eli Lilly says it will file for approval of next-generation obesity drug in 2027

7 days ago

Ozempic face? Botox boom boosted by 'sagging face' trend, Swiss firm says

7 days ago

What Trump's generic drug tariffs could mean for patients, drugmakers and prices

7 days ago

RFK Jr. says cyclospora outbreak is 'under control'

8 days ago

Cardinal Health's latest deals won't move the needle overnight. They still matter.

8 days ago

Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising

9 days ago

The FDA made a reversal on cyclosporiasis, but it still thinks iceberg lettuce is to blame

9 days ago

What to know about testosterone replacement as U.S. military plans to test troops

9 days ago

Market case for psychedelic drugs to treat mental health gets a big buy signal

9 days ago

Fat cat? Weight-loss drugs may be coming for your overweight pet

12 days ago

Trump rips Canada for wildfire smoke, threatens to raise tariffs

12 days ago

Taco Bell says it has removed lettuce linked to cyclosporiasis outbreak from its restaurants

12 days ago

World's largest olive oil company says market has 'definitively' entered new phase

13 days ago

Buy the contractor before the renovation is complete: This stock's next growth phase is taking shape

13 days ago

3 of our stocks rode the AI rally, while 3 others fell out of favor since last month

13 days ago

Eli Lilly to buy psychedelics maker AtaiBeckley for $2.8 billion

13 days ago

UnitedHealth beats quarterly estimates, hikes profit outlook

14 days ago

J&J falls despite a beat-and-raise quarter. Why we're raising our price target anyways

14 days ago

Biotech's recovery isn't a 'head fake.' These 3 stocks could lead the next leg up

15 days ago

A tiny GLP-1 implant is the latest bet to help patients maintain weight loss

15 days ago

AstraZeneca's trial flop raises a bigger question: Is its pipeline premium too vulnerable?

19 days ago